Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Iversen

Showing results (161-170 of 226) with videos related to

Pageof 23
Sort By:
Scientific Reports|November 9, 2019
Direct observation of Thermomyces lanuginosus lipase diffusional states by Single Particle Tracking and their remodeling by mutations and inhibitionSøren S-R Bohr, Philip M Lund, Amalie S Kallenbach, et al.
American Heart Journal|November 18, 2005
A randomized clinical trial of hospital-based, comprehensive cardiac rehabilitation versus usual care for patients with congestive heart failure, ischemic heart disease, or high risk of ischemic heart disease (the DANREHAB trial)--design, intervention, and populationAnn-Dorthe Olsen Zwisler, Lone Schou, Anne Merete Boas Soja, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 21, 2006
Protein expression of TNF-alpha in psoriatic skin is regulated at a posttranscriptional level by MAPK-activated protein kinase 2Claus Johansen, Anne Toftegaard Funding, Kristian Otkjaer, et al.
BMC Dermatology|October 8, 2016
Treatment of plaque psoriasis with an ointment formulation of the Janus kinase inhibitor, tofacitinib: a Phase 2b randomized clinical trialKim A Papp, Robert Bissonnette, Melinda Gooderham, et al.
Experimental Dermatology|February 14, 2021
The HSP90 inhibitor RGRN-305 exhibits strong immunomodulatory effects in human keratinocytesRikke S Hansen, Katrine K H Thuesen, Anne Bregnhøj, et al.
The Journal of Investigative Dermatology|January 27, 2007
IL-20 gene expression is induced by IL-1beta through mitogen-activated protein kinase and NF-kappaB-dependent mechanismsKristian Otkjaer, Knud Kragballe, Claus Johansen, et al.
The Journal of Investigative Dermatology|May 22, 2025
Oral Roflumilast Suppresses Proinflammatory Cytokine Signaling and Reduces CD4+ T-Cell and Neutrophil Infiltration in PsoriasisElena Baez, Mette Gyldenløve, Hakim Ben Abdallah, et al.
Molecular and Cellular Therapies|January 29, 2016
Interleukin 20 regulates dendritic cell migration and expression of co-stimulatory moleculesRikke Bech, Babak Jalilian, Ralf Agger, et al.
Journal of Drugs in Dermatology : JDD|April 14, 2021
Effect of Ixekizumab on Patient Reported Outcomes and Quality of Life in Patients With Moderate-to-Severe Plaque Psoriasis: 5-Year Results from the UNCOVER-1 and -2 StudiesMelinda J Gooderham, Boni Elewski, Matthias Augustin, et al.
The Ocular Surface|May 7, 2026
Proteomic Profiling of Tear Fluid in Patients with Atopic KeratoconjunctivitisLars Iversen, Manuel Ramirez Garrastacho, Pernille May Hansen, et al.
Pageof 23

Showing results (161-170 of 226) with videos related to

Sort By:
Pageof 23
Scientific Reports|November 9, 2019
Direct observation of Thermomyces lanuginosus lipase diffusional states by Single Particle Tracking and their remodeling by mutations and inhibitionSøren S-R Bohr, Philip M Lund, Amalie S Kallenbach, et al.
American Heart Journal|November 18, 2005
A randomized clinical trial of hospital-based, comprehensive cardiac rehabilitation versus usual care for patients with congestive heart failure, ischemic heart disease, or high risk of ischemic heart disease (the DANREHAB trial)--design, intervention, and populationAnn-Dorthe Olsen Zwisler, Lone Schou, Anne Merete Boas Soja, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 21, 2006
Protein expression of TNF-alpha in psoriatic skin is regulated at a posttranscriptional level by MAPK-activated protein kinase 2Claus Johansen, Anne Toftegaard Funding, Kristian Otkjaer, et al.
BMC Dermatology|October 8, 2016
Treatment of plaque psoriasis with an ointment formulation of the Janus kinase inhibitor, tofacitinib: a Phase 2b randomized clinical trialKim A Papp, Robert Bissonnette, Melinda Gooderham, et al.
Experimental Dermatology|February 14, 2021
The HSP90 inhibitor RGRN-305 exhibits strong immunomodulatory effects in human keratinocytesRikke S Hansen, Katrine K H Thuesen, Anne Bregnhøj, et al.
The Journal of Investigative Dermatology|January 27, 2007
IL-20 gene expression is induced by IL-1beta through mitogen-activated protein kinase and NF-kappaB-dependent mechanismsKristian Otkjaer, Knud Kragballe, Claus Johansen, et al.
The Journal of Investigative Dermatology|May 22, 2025
Oral Roflumilast Suppresses Proinflammatory Cytokine Signaling and Reduces CD4+ T-Cell and Neutrophil Infiltration in PsoriasisElena Baez, Mette Gyldenløve, Hakim Ben Abdallah, et al.
Molecular and Cellular Therapies|January 29, 2016
Interleukin 20 regulates dendritic cell migration and expression of co-stimulatory moleculesRikke Bech, Babak Jalilian, Ralf Agger, et al.
Journal of Drugs in Dermatology : JDD|April 14, 2021
Effect of Ixekizumab on Patient Reported Outcomes and Quality of Life in Patients With Moderate-to-Severe Plaque Psoriasis: 5-Year Results from the UNCOVER-1 and -2 StudiesMelinda J Gooderham, Boni Elewski, Matthias Augustin, et al.
The Ocular Surface|May 7, 2026
Proteomic Profiling of Tear Fluid in Patients with Atopic KeratoconjunctivitisLars Iversen, Manuel Ramirez Garrastacho, Pernille May Hansen, et al.
Pageof 23